J Am Pharm Assoc (2003). 2023 Nov-Dec;63(6):1776-1784.e3. doi: 10.1016/j.japh.2023.08.023. Epub 2023 Sep 9.
Patients' perceptions of their interaction with pharmacists can affect how they use this resource for chronic disease care.
This qualitative study explored pharmacist-patient interactions and patients' perceptions of pharmacists' roles in cardiovascular disease (CVD) and inflammatory bowel disease (IBD).
Patient volunteers, recruited through Janssen's Patient Engagement Research Council program, completed a 15-minute prework survey before a 90-minute live virtual focus group session to provide feedback on pharmacist-patient interactions, the pharmacist's role in patient care, and recommendations for improvement.
In total, 27 patients participated. Among patients with CVD (n=18), 56% were female, 61% aged ≥65 years, and 39%/39% Black/White. Of those with IBD (n=9), 56% were female, 89% aged 25-44 years, and 33%/56% Black/White. In the CVD cohort, patients conversed with their pharmacists at least monthly, on average. Patients were generally happy with their relationship with their pharmacist, viewing pharmacists as a trusted resource for medication information. Polypharmacy was common in the CVD cohort (mean, 10.8 medications). For patients with IBD, pharmacist-patient interactions were less frequent, relationships were generally perceived as transactional, patients took fewer medications (mean, 3.2), and felt uncomfortable discussing their disease in public. All patients (CVD and IBD) were unaware of pharmacists' medical training/knowledge. Recommendations included private spaces for sensitive conversations, phone/text support, in-depth regular check-ins, and proactive communication to highlight that the pharmacist's role is to provide patient-centered holistic care.
This research demonstrates a lack of understanding of pharmacist training, accessibility and role among patients with chronic disease, and highlights opportunities to amend delivery of care. These insights can be used to inform strategies and approaches tailored to address unique needs of specific patient populations to enhance pharmacist-patient interactions.
患者对其与药剂师互动的看法会影响他们对慢性病护理的利用程度。
本定性研究探讨了药剂师与患者之间的互动，以及患者对药剂师在心血管疾病（CVD）和炎症性肠病（IBD）中的角色的看法。
通过 Janssen 的患者参与研究委员会计划招募患者志愿者，在 90 分钟的虚拟现场焦点小组会议前完成 15 分钟的预调查，以提供关于药剂师与患者互动、药剂师在患者护理中的作用以及改进建议的反馈。
共有 27 名患者参与。CVD 组（n=18）中，56%为女性，61%年龄≥65 岁，39%/39%为黑种人/白种人。IBD 组（n=9）中，56%为女性，89%年龄在 25-44 岁之间，33%/56%为黑种人/白种人。在 CVD 组中，患者平均每月至少与药剂师交谈一次。患者对他们与药剂师的关系普遍感到满意，将药剂师视为药物信息的可靠资源。CVD 组患者普遍服用多种药物（平均 10.8 种）。IBD 组患者与药剂师的互动较少，关系普遍被认为是交易性的，患者服用的药物较少（平均 3.2 种），并且不愿在公众面前讨论他们的疾病。所有患者（CVD 和 IBD）都不知道药剂师的医学培训/知识。建议包括为敏感对话提供私人空间、电话/短信支持、定期深入检查以及主动沟通以突出药剂师的角色是提供以患者为中心的全面护理。
这项研究表明，慢性病患者对药剂师培训、可及性和角色缺乏了解，并强调了改善护理提供的机会。这些见解可用于为特定患者群体提供有针对性的策略和方法，以满足他们的独特需求，从而加强药剂师与患者的互动。
